Longevica's goal is to validate the pipeline of turning scientific research into consumer-ready products.
Adil estimates that today’s growth factor costs $2 million per gram to make, but she believes that with efforts from Tiamat Sciences and others, that cost could come down 10 times.
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round. Generate Biomedicines
The company has been busy strengthening its supply chain to gear up for scaling its product. Additionally, it hired a head of growth and a community engagement and success manager.
Cellino, a company developing a platform to automate stem cell production, presented today at TechCrunch Disrupt 2021’s Startup Battlefield to detail how its system, which combines AI technology
Human life expectancy increased from 31 years in 1900 to 72 years in 2017. Today, we are on the cusp of another healthcare revolution driven by artificial intelligence.
Stockeld Chunk is made using fermented legumes, which gives the cheese a feta-like look and feel and contains 13% protein.
Decisions about protecting your company’s IP can’t wait — founders must start aligning their IP and company strategies as soon as possible, even during the formation of the company itself.
Bioengineering may soon provide compelling, low-carbon alternatives in industries where even the best methods produce significant emissions. Utilizing natural and engineered biological process has led
We’re entering a phase in the COVID-19 pandemic where transmission is going to go through the roof because of the Delta variant. But as vaccinations ramp up around the world, the main cost to so
The numbers don’t lie. According to DocSend, the average pitch deck is reviewed for just three minutes. And if you think a senior VC is studying the presentation your team crafted for months as
In a joint address to Congress last night, President Biden updated the nation on vaccination efforts and outlined his administration’s ambitious goals. Biden’s first 100 days have been characteriz
The median step up in biotech valuations from seed to Series A is now 2x, higher than in all later rounds. As a result, biotech startups will continue to attract more investment at earlier stages.
A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. Longevica says it has attracted a total of $13 million fr
The sweeping infrastructure package put forward today by President Joe Biden comes with a price tag of roughly $2 trillion (and hefty tax hikes), but gives startups and the broader tech industry about
A startup from Europe is joining the race to become the first big provider of lab-grown fish. Bluu Biosciences has raised €7 million in a round of financing from investors including Manta Ray Ventur
Antibiotic resistance is one of the biggest potential threats to global health today. But Locus Biosciences is hoping that their crPhage technology might provide a new solution. Based in North Carolin
Health and life science specialist investment firm Foresite Capital has raised a new fund, its fifth to date, totaling $969 million in commitments from LPs. This is the firm’s largest fund to da
Just two years after its founding, biotech startup Immunai has raised $60 million in Series A funding, bringing its total raised to over $80 million. Despite its youth, Immunai has already established
As the vaccination campaign to counter COVID-19 gets underway (albeit with a rocky start), a number of companies are attempting to support its rollout in a variety of ways. Healthvana, a health tech s